In a filing, Rhythm Pharmaceuticals Inc. revealed its Director TETRAULT LYNN A. unloaded Company’s shares for reported $0.45 million on Aug 12 ’24. In the deal valued at $44.65 per share,10,000 shares were sold. As a result of this transaction, TETRAULT LYNN A. now holds 3,000 shares worth roughly $0.14 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Cramer Pamela J. sold 49,006 shares, generating $2,212,498 in total proceeds. Upon selling the shares at $45.15, the Chief Human Resources Officer now owns 13,500 shares.
Before that, LYNN TETRAULT393 COMMONWEALTH bought 10,000 shares. Rhythm Pharmaceuticals Inc. shares valued at $452,600 were divested by the Director at a price of $45.26 per share.
BofA Securities downgraded its Rhythm Pharmaceuticals Inc. [RYTM] rating to a Neutral from a a Buy in a research note published on May 08, 2024; the price target was decreased to $42 from $49. A number of analysts have revised their coverage, including Morgan Stanley’s analysts, who increased its forecast for the stock in mid December from “an Equal-weight” to “an Overweight”. BofA Securities also remained covering RYTM and has increased its forecast on August 01, 2023 with a “Buy” recommendation from previously “Neutral” rating.
Price Performance Review of RYTM
On Tuesday, Rhythm Pharmaceuticals Inc. [NASDAQ:RYTM] saw its stock fall -3.16% to $45.61. Over the last five days, the stock has lost -0.78%. Rhythm Pharmaceuticals Inc. shares have fallen nearly -0.78% since the year began. Nevertheless, the stocks have risen 81.57% over the past one year. While a 52-week high of $53.92 was reached on 07/17/24, a 52-week low of $20.97 was recorded on 05/29/24. SMA at 50 days reached $45.29, while 200 days put it at $41.63.
Levels Of Support And Resistance For RYTM Stock
The 24-hour chart illustrates a support level at 44.16, which if violated will result in even more drops to 42.72. On the upside, there is a resistance level at 47.61. A further resistance level may holdings at 49.62. The Relative Strength Index (RSI) on the 14-day chart is 48.36, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.86, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 36.63%. Stochastics%K at 64.22% indicates the stock is a holding.
How much short interest is there in Rhythm Pharmaceuticals Inc.?
A steep rise in short interest was recorded in Rhythm Pharmaceuticals Inc. stocks on 2024-07-31, growing by 0.94 million shares to a total of 10.18 million shares. Yahoo Finance data shows the prior-month short interest on 2024-06-28 was 9.24 million shares. There was a rise of 9.26%, which implies that there is a positive sentiment for the stock.
